NFKB1 and neoplasm: Our studies demonstrate that activation of NF-κB signaling contributes to osteoclastogenesis in the bone environment (Fig. 3) and inactivation of NF-κB signaling inhibits tumor growth in the bone in both of PC3 and C4-2B cells (Fig. 5).